HLB Science (XKRX:343090) Debt-to-Equity : 0.47 (As of Dec. 2024)

View and export this data going back to 2020. Start your Free Trial

What is HLB Science Debt-to-Equity?

HLB Science's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was ₩1,226.30 Mil. HLB Science's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was ₩0.00 Mil. HLB Science's Total Stockholders Equity for the quarter that ended in Dec. 2024 was ₩2,586.05 Mil. HLB Science's debt to equity for the quarter that ended in Dec. 2024 was 0.47.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for HLB Science's Debt-to-Equity or its related term are showing as below:

XKRX:343090' s Debt-to-Equity Range Over the Past 10 Years
Min: -1.41 Med: 0.47 Max: 0.68
Current: 0.47

During the past 3 years, the highest Debt-to-Equity Ratio of HLB Science was 0.68. The lowest was -1.41. And the median was 0.47.

XKRX:343090's Debt-to-Equity is ranked worse than
74.31% of 1012 companies
in the Biotechnology industry
Industry Median: 0.14 vs XKRX:343090: 0.47

HLB Science Debt-to-Equity Historical Data

The historical data trend for HLB Science's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HLB Science Debt-to-Equity Chart

HLB Science Annual Data

Trend

Dec22

Dec23

Dec24

Debt-to-Equity

-1.41

0.68

0.47

HLB Science Semi-Annual Data
	Dec22	Dec23	Dec24
Debt-to-Equity	-1.41	0.68	0.47

Competitive Comparison of HLB Science's Debt-to-Equity

For the Biotechnology subindustry, HLB Science's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

HLB Science's Debt-to-Equity Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, HLB Science's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where HLB Science's Debt-to-Equity falls into.

Save Embed

;

Save Embed

;

HLB Science Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

HLB Science's Debt to Equity Ratio for the fiscal year that ended in Dec. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1226.295	+	0)	/	2586.05
	=	0.47

HLB Science's Debt to Equity Ratio for the quarter that ended in Dec. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1226.295	+	0)	/	2586.05
	=	0.47

HLB Science (XKRX:343090) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

HLB Science Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of HLB Science's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

HLB Science Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HLB Science Inc (XKRX:343090) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

66, Achasan-ro, 6th Floor, Seongdong-gu, Seoul, KOR

Website

http://www.hlbscience.com

HLB Science Inc develops biological new drugs to treat infectious diseases. Its product pipelines includes DD-S052P, DD-A279, and DD-A514.

HLB Science Headlines

No Headlines